@article{a253f62138c640e7bc90c3b70f8c2183,
title = "Three out of four disease-modifying anti-rheumatic drug-naive rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12months: results from the FIN-ERA cohort",
keywords = "NECROSIS-FACTOR INHIBITORS, COMBINATION THERAPY, CLINICAL-PRACTICE, ESPOIR COHORT, TRIALS, CRITERIA, OUTCOMES, 3121 General medicine, internal medicine and other clinical medicine, 317 Pharmacy",
author = "T. Rannio and J. Asikainen and P. Hannonen and T. Yli-Kerttula and P. Ekman and L. Piril{\"a} and L. Kuusalo and M. Mali and M. Puurtinen-Vilkki and S. Kortelainen and J. Paltta and K. Taimen and M. Kauppi and K. Laiho and S. Nyrhinen and H. Makinen and P. Isomaki and T. Uotila and K. Aaltonen and H. Kautiainen and T. Sokka",
year = "2017",
doi = "10.1080/03009742.2016.1266029",
language = "English",
volume = "46",
pages = "425--431",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "Taylor & Francis",
number = "6",
}